Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ann Surg Oncol. 2024 Oct;31(10):6931-6938. doi: 10.1245/s10434-024-15943-0. Epub 2024 Jul 31.
Palliative decompressive gastrostomy tubes are intended to relieve the severe physical symptoms of malignant small bowel obstruction (SBO) near the end of life. The objective of this study was to assess the impact of palliative decompressive gastrostomy tube on patient and caregiver well-being.
We prospectively enrolled patients with a malignant SBO and their caregivers at the time of informed consent for decompressive gastrostomy tube placement. We collected the Edmonton Symptom Assessment Scale (ESAS) and the Functional Assessment of Chronic Illness Therapy-Palliative (FACIT-Pal-14) surveys from patients at baseline and at 2-week post-procedure follow-up. The Caregiver Burden Scale survey was administered to caregivers at baseline. Survey scores were compared using paired t-tests. We also conducted semistructured interviews with patients and their caregivers at two-week follow-up until thematic saturation was reached. Content analysis was used to identify themes with two independent coders.
We enrolled 15 patient-caregiver dyads. Preprocedure, the median caregiver burden scale score was 37.5 (significant burden ≥ 21). Eight patients (53%) survived to 2 weeks; among these patients, median ESAS scores (51 versus 43.5, p < 0.001) and median FACIT-Pal-14 scores (22 versus 32, p = 0.015) were significantly improved at 2-week follow-up. Interviews revealed three major themes: improved symptom management, new stressors, and opportunities for better education and resources.
Decompressive gastrostomy tubes effectively alleviated symptoms in patients with inoperable malignant SBOs. This palliative intervention may provide greater benefit if performed earlier, and caregivers and patients need improved resources and education for tube management to minimize added stressors.
姑息性减压胃造口管旨在缓解生命末期恶性小肠梗阻(SBO)的严重身体症状。本研究的目的是评估姑息性减压胃造口管对患者和护理人员的影响。
我们前瞻性地招募了恶性 SBO 患者及其护理人员,在知情同意进行减压胃造口管放置时。我们从患者基线和 2 周术后随访时收集了 Edmonton 症状评估量表(ESAS)和慢性疾病治疗-姑息功能评估量表(FACIT-Pal-14)。在基线时向护理人员发放了照顾者负担量表调查。使用配对 t 检验比较调查评分。我们还在 2 周随访时对患者及其护理人员进行了半结构访谈,直到达到主题饱和度。使用两位独立编码员进行内容分析以确定主题。
我们招募了 15 个患者-护理人员二人组。术前,照顾者负担量表的中位数为 37.5(显著负担≥21)。8 名患者(53%)存活至 2 周;在这些患者中,ESAS 评分中位数(51 比 43.5,p<0.001)和 FACIT-Pal-14 评分中位数(22 比 32,p=0.015)在 2 周随访时显著改善。访谈揭示了三个主要主题:改善症状管理、新的压力源以及更好的教育和资源机会。
减压胃造口管可有效缓解不可手术的恶性 SBO 患者的症状。如果更早进行这种姑息性干预,可能会带来更大的益处,并且需要为管饲管理提供更好的资源和教育,以减轻额外的压力源。